Edition:
United States

People: AbbVie Inc (ABBV.K)

ABBV.K on New York Consolidated

72.75USD
29 Jun 2017
Change (% chg)

$-0.17 (-0.23%)
Prev Close
$72.92
Open
$73.15
Day's High
$73.17
Day's Low
$72.61
Volume
596,229
Avg. Vol
5,944,544
52-wk High
$73.67
52-wk Low
$55.06

Gonzalez, Richard 

Mr. Richard A. Gonzalez is Chairman of the Board, Chief Executive Officer of Abbvie Inc. He is the chairman and chief executive officer of AbbVie. He served as Abbott's executive vice president of the pharmaceutical products group from July 2010 to December 2012, and was responsible for Abbott's worldwide pharmaceutical business, including commercial operations, research and development, and manufacturing. He also served as president, Abbott Ventures Inc., Abbott's medical technology investment arm, from 2009 to 2011. Mr. Gonzalez joined Abbott in 1977 and held various management positions before briefly retiring in 2007, including: Abbott's president and chief operating officer; president, chief operating officer of Abbott's Medical Products Group; senior vice president and president of Abbott's former Hospital Products Division; vice president and president of Abbott's Health Systems Division; and divisional vice president and general manager for Abbott's Diagnostics Operations in the United States and Canada.

Basic Compensation

Total Annual Compensation, USD 2,946,760
Restricted Stock Awards, USD 9,747,460
Long-Term Incentive Plans, USD --
All Other, USD 6,498,190
Fiscal Year Total, USD 19,192,400

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 285,953 7,989,720.00
Name Fiscal Year Total

Richard Gonzalez

19,192,400

William Chase

7,613,790

Michael Severino

6,603,800

Laura Schumacher

7,306,340

Carlos Alban

7,049,640

Henry Gosebruch

--
As Of  30 Dec 2016